Literature DB >> 10408561

VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.

N Kawahara1, H Kume, K Ueki, K Mishima, T Sasaki, T Kirino.   

Abstract

The authors present a case of endolymphatic sac tumor, a rare adenomatous tumor of the temporal bone, in a patient with von Hippel-Lindau (VHL) disease. Sequencing and microsatellite analysis of DNA samples from the tumor showed a 1-base pair deletion in exon 1 of the VHL gene and loss of heterozygosity at chromosome 3p25.5, the locus for the VHL gene. The results indicate that VHL gene inactivation contributed to the oncogenesis of endolymphatic sac tumor and provide molecular genetic proof that this tumor is associated with VHL disease.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10408561     DOI: 10.1212/wnl.53.1.208

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  3 in total

1.  The endolymphatic sac tumor: challenges in the eradication of a localized disease.

Authors:  Vittoria Sykopetrites; Gianluca Piras; Annalisa Giannuzzi; Antonio Caruso; Abdelkader Taibah; Mario Sanna
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-05       Impact factor: 2.503

2.  Endolymphatic sac tumors: experience of three cases.

Authors:  Pierre-Louis Bastier; Erwan de Mones; Magali Marro; Wael Elkhatib; Valérie Franco-Vidal; Dominique Liguoro; Vincent Darrouzet
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-05       Impact factor: 2.503

3.  Pathology of the Nervous System in Von Hippel-Lindau Disease.

Authors:  Alexander O Vortmeyer; Ahmed K Alomari
Journal:  J Kidney Cancer VHL       Date:  2015-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.